title: [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
abstract: OBJECTIVE
  To evaluate the efficacy of finasteride in the treatment of prostatic origin haematuria.
  
  
  METHODS
  This is a prospective observational study in 29 patients with hematuria from a demonstrated prostatic-origin which were treated with finasteride 5 mg/day. 58.6% had undergone previous prostatic surgery. Both previous-to-treatment hematuria and response to treatment were evaluated under the Puchner & Miller's criteria.
  
  
  RESULTS
  Response rate was 86.2% without additional haematuria episodes. The remaining patients had mild haematuria episodes during follow-up. No patient needed surgery.
  
  
  CONCLUSIONS
  Finasteride is effective in the treatment of prostatic-origin haematuria.
authors.affiliation: Servicio de Urología, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, España.
authors.forename: Juan
authors.initials: J
authors.lastname: Palou Redorta
authors.forename: Luis
authors.initials: L
authors.lastname: Gausa Gascon
authors.forename: José
authors.initials: J
authors.lastname: Salvador Bayarre
authors.forename: Félix
authors.initials: F
authors.lastname: Millán Rodríguez
authors.forename: José
authors.initials: J
authors.lastname: Segarra Tomás
authors.forename: Humberto
authors.initials: H
authors.lastname: Villavicencio Mavrich
mesh_terms: D058891:5-alpha Reductase Inhibitors; D000368:Aged; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006417:Hematuria / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000453:epidemiology; D011183:Postoperative Complications; D011446:Prospective Studies; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D020728:Transurethral Resection of Prostate; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000453:epidemiology
chemical_list: D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D018120:Finasteride